Assessing health economic outcome in Alzheimer's disease clinical trials.
This paper reviews methodological considerations in collecting data on economic endpoints and conducting economic evaluation alongside clinical trials in Alzheimer's disease (AD).
Jonsson
L
L
L. Jonsson, European Health Economics, Stockholm, Sweden.
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000191:economics*; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D003657:Decision Making; D017048:Health Care Costs; D006801:Humans; D018697:Nootropic Agents / Q000191:economics* / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care
D018697:Nootropic Agents